USX:AXDX - Accelerate Diagnostics Inc (USD 9.25) Accelerate Diagnostics Inc
Sector: Health Technology, Industry: Medical Specialties
Add to Watchlist

Yahoo Finance

USD 9.25    +0.570 (+6.57%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

9 Apr 2020


9 Apr 2020

Day Change: 0.570 (6.57%)

52 Wk Range: 4.53 - 24.0

Day's Range: 8.79 - 9.64

Last Volume: 646,268

Current Yield: 0%

Projected Yield: 0%

Open: USD 8.95

9 Apr 2020

Metric AXDX S.Median
Beta 1.31 0.84
VaR 39.59 25.23
E.Shortfall 68.69 45.03
Liquidity 255.52K 95.2K


9 Apr 2020

PE: -5.996

Market Cap: 510.6M

Price Over Book: 49.961

Price Over Sales: 66.75

Return On Assets: -57.8%

Return On Equity: -833.3%

Price Over NAV: [Friends Only]


CEO: Lawrence L. Mehren

Headquarters: TUCSON

Employees: 287

Sector: Health Technology

Industry: Medical Specialties

Useful Links


Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States. It offers Accelerate Pheno system, an vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms, as well as yeast. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was founded in 1982 and is headquartered in Tucson, Arizona.